Allergen-encoded signals that control allergic responses
- PMID: 26658015
- PMCID: PMC4863991
- DOI: 10.1097/ACI.0000000000000233
Allergen-encoded signals that control allergic responses
Abstract
Purpose of review: The purpose is to review the important recent advances made in how innate immune cells, microbes, and the environment contribute to the expression of allergic disease, emphasizing the allergen-related signals that drive allergic responses.
Recent findings: The last few years have seen crucial advances in how innate immune cells such as innate lymphoid cells group 2 and airway epithelial cells and related molecular pathways through organismal proteinases and innate immune cytokines, such as thymic stromal lymphopoietin, IL-25, and IL-33 contribute to allergy and asthma. Simultaneously with these advances, important progress has been made in our understanding of how the environment, and especially pathogenic organisms, such as bacteria, viruses, helminths, and especially fungi derived from the natural and built environments, either promote or inhibit allergic inflammation and disease. Of specific interest are how lipopolysaccharide mediates its antiallergic effect through the ubiquitin modifying factor A20 and the antiallergic activity of both helminths and protozoa.
Summary: Innate immune cells and molecular pathways, often activated by allergen-derived proteinases acting on airway epithelium and macrophages as well as additional unknown factors, are essential to the expression of allergic inflammation and disease. These findings suggest numerous future research opportunities and new opportunities for therapeutic intervention in allergic disease.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Ather JL, Foley KL, Suratt BT, et al. Airway epithelial NF-kappaB activation promotes the ability to overcome inhalational antigen tolerance. Clin Exp Allergy. 2015;45:1245–1258. Using an OVA-induced inhalational tolerance model in transgenic mice capable of expressing constitutively active IκB kinase β (CAIKKβ) in airway epithelium, this study demonstrates that soluble mediators generated in response to airway epithelial NF-κB activation orchestrate the breaking of inhalational tolerance and allergen sensitization through IL-1 and IL-4 signaling on CD103+ and CD11bHI pulmonary dendritic cells as well as ILC2 and CD4+ T cells. - PMC - PubMed
-
- Tao X, Guangyan L, Yun Z, et al. Rho-kinase inhibitor fasudil reduces allergic airway inflammation and mucus hypersecretion by regulating STAT6 and NFkappaB. Clin Exp Allergy. 2015 Fasudil is a selective RhoA/Rho kinase inhibitor that has been used to treat pulmonary hypertension. This study shows that fasudil plays a negative regulatory role in allergen-induced mucus secretion by decreasing the expressions of NF-κB and signal transducer and activator of transcription 6 in OVA-challenged mice, as well as HDM extract-challenged human AECs (16HBE) - PubMed
-
- Polosukhin VV, Polosukhin IV, Hoskins A, et al. Glutathione S-transferase M1 modulates allergen-induced NF-kappaB activation in asthmatic airway epithelium. Allergy. 2014;69:1666–1672. In this study the investigators examined endobronchial biopsies and bronchoalveolar lavage fluid samples collected from glutathione S-transferase mu (GSTM) 1+ and GSTM1null human atopic asthmatic patients and found that allergen-induced neutrophilic airway inflammation and upregulation of IL-8inGSTM1+ asthmatics is associated with NF-κB activation in AECs. This provides a potential mechanism to explain the link between GSTM1 polymorphisms and airway neutrophilia in atopic asthma. - PMC - PubMed
-
- Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med. 2012;18:684–692. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials